Systematic review and meta-analysis of 38 mouse studies: genetic or drug inhibition of CCR2 (SMD -1.14) and CCR5 (SMD -1.06) reduced atherosclerotic lesion size and macrophage load; CCR1 effects were less clear, with benefit only in males.
Meta-analysisn = 38 studies
Shoaran et al. Pharmacological and Genetic Targeting of Inflammatory Chemokine Receptors CCR1, CCR2, and CCR5 in Atherosclerosis: A Systematic Review and Meta-Analysis of Preclinical Studies